Cargando…
Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan
Objective. The objective of this study was to evaluate the frequency and outcome of graft versus host disease after stem cell transplantation for various haematological disorders in Pakistan. Materials and Methods. Pretransplant workup of the patient and donor was performed. Mobilization was done wi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712246/ https://www.ncbi.nlm.nih.gov/pubmed/23936661 http://dx.doi.org/10.1155/2013/232519 |
_version_ | 1782277048386977792 |
---|---|
author | Ali, Natasha Adil, Salman Naseem Shaikh, Mohammad Usman Masood, Nehal |
author_facet | Ali, Natasha Adil, Salman Naseem Shaikh, Mohammad Usman Masood, Nehal |
author_sort | Ali, Natasha |
collection | PubMed |
description | Objective. The objective of this study was to evaluate the frequency and outcome of graft versus host disease after stem cell transplantation for various haematological disorders in Pakistan. Materials and Methods. Pretransplant workup of the patient and donor was performed. Mobilization was done with G-CSF 300 μg twice daily for five day. Standard GvHD prophylaxis was done with methotrexate 15 mg/m(2) on day +1 followed by 10 mg/m(2) on days +3 and +6 and cyclosporine. Grading was done according to the Glucksberg classification. Results. A total of 153 transplants were done from April 2004 to December 2011. Out of these were allogeneic transplants. There were females and males. The overall frequency of any degree of graft versus host disease was 34%. Acute GvHD was present in patients while had chronic GvHD. Grade II GvHD was present in patients while grade III and IV GvHD was seen in patients each. Acute myeloid leukemia and chronic myeloid leukemia were most commonly associated with GvHD. The mortality in acute and chronic GvHD was 8.8% and 12% respectively. Conclusion. The frequency of graft versus host disease in this study was 34% which is lower compared to international literature. The decreased incidence can be attributed to reduced diversity of histocompatibility antigens in our population. |
format | Online Article Text |
id | pubmed-3712246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-37122462013-08-09 Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan Ali, Natasha Adil, Salman Naseem Shaikh, Mohammad Usman Masood, Nehal ISRN Hematol Clinical Study Objective. The objective of this study was to evaluate the frequency and outcome of graft versus host disease after stem cell transplantation for various haematological disorders in Pakistan. Materials and Methods. Pretransplant workup of the patient and donor was performed. Mobilization was done with G-CSF 300 μg twice daily for five day. Standard GvHD prophylaxis was done with methotrexate 15 mg/m(2) on day +1 followed by 10 mg/m(2) on days +3 and +6 and cyclosporine. Grading was done according to the Glucksberg classification. Results. A total of 153 transplants were done from April 2004 to December 2011. Out of these were allogeneic transplants. There were females and males. The overall frequency of any degree of graft versus host disease was 34%. Acute GvHD was present in patients while had chronic GvHD. Grade II GvHD was present in patients while grade III and IV GvHD was seen in patients each. Acute myeloid leukemia and chronic myeloid leukemia were most commonly associated with GvHD. The mortality in acute and chronic GvHD was 8.8% and 12% respectively. Conclusion. The frequency of graft versus host disease in this study was 34% which is lower compared to international literature. The decreased incidence can be attributed to reduced diversity of histocompatibility antigens in our population. Hindawi Publishing Corporation 2013-06-27 /pmc/articles/PMC3712246/ /pubmed/23936661 http://dx.doi.org/10.1155/2013/232519 Text en Copyright © 2013 Natasha Ali et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Ali, Natasha Adil, Salman Naseem Shaikh, Mohammad Usman Masood, Nehal Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title_full | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title_fullStr | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title_full_unstemmed | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title_short | Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan |
title_sort | frequency and outcome of graft versus host disease after stem cell transplantation: a six-year experience from a tertiary care center in pakistan |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712246/ https://www.ncbi.nlm.nih.gov/pubmed/23936661 http://dx.doi.org/10.1155/2013/232519 |
work_keys_str_mv | AT alinatasha frequencyandoutcomeofgraftversushostdiseaseafterstemcelltransplantationasixyearexperiencefromatertiarycarecenterinpakistan AT adilsalmannaseem frequencyandoutcomeofgraftversushostdiseaseafterstemcelltransplantationasixyearexperiencefromatertiarycarecenterinpakistan AT shaikhmohammadusman frequencyandoutcomeofgraftversushostdiseaseafterstemcelltransplantationasixyearexperiencefromatertiarycarecenterinpakistan AT masoodnehal frequencyandoutcomeofgraftversushostdiseaseafterstemcelltransplantationasixyearexperiencefromatertiarycarecenterinpakistan |